Keyphrases
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Inflammatory Mediators
100%
Lubiprostone
100%
Drug-induced
100%
EP4 Receptor
100%
Small Bowel Injury
100%
Indomethacin
62%
Enteropathy
37%
Tumor Necrosis Factor-α
25%
Small Intestine
25%
Inducible Nitric Oxide Synthase
25%
Hypermobility
25%
Fluid Secretion
25%
Bicyclol
12%
Mechanism of Action
12%
Chloride Channel
12%
Receptor Subtypes
12%
Fatty Acids
12%
Protective Effect
12%
Phenyl
12%
Functional Change
12%
Functional Constipation
12%
Sprague-Dawley Rats
12%
Functional Alterations
12%
Mucus
12%
Cystic Fibrosis Transmembrane Conductance Regulator
12%
Hemorrhagic Disease
12%
ClC-2 Chloride Channel
12%
Direct Activation
12%
Intestinal Fluid Secretion
12%
Cyano
12%
Bacterial Invasion
12%
CFTR Inhibitor
12%
Prostaglandin E1 (PGE1)
12%
Mucus Secretion
12%
Functional Mechanism
12%
Intestinal Lesions
12%
Irritable Bowel Syndrome
12%
Chloride Channel Protein
12%
Butyric Acid
12%
EP4 Antagonist
12%
Medicine and Dentistry
Receptor
100%
Lubiprostone
100%
Nonsteroid Antiinflammatory Agent
100%
Inflammatory Mediator
100%
Intestine Injury
100%
Indometacin
62%
Secretion (Process)
37%
Enteropathy
37%
Chloride Channel
37%
Tumor Necrosis Factor
25%
Small Intestine
25%
Inducible Nitric Oxide Synthase
25%
Intestinal Dysmotility
25%
Receptor Subtype
12%
Fatty Acid
12%
Upregulation
12%
Mucus
12%
Chronic Constipation
12%
Channel Protein
12%
Cystic Fibrosis
12%
Irritable Bowel Syndrome
12%
Butyric Acid
12%
Mucus Secretion
12%
Prostaglandin E
12%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Non-Steroidal Anti-Inflammatory Drug
100%
Intestine Injury
100%
Lubiprostone
100%
Indometacin
62%
Chloride Channel
37%
Enteropathy
37%
Tumor Necrosis Factor
25%
Inducible Nitric Oxide Synthase
25%
Intestinal Dysmotility
25%
Fatty Acid
12%
Receptor Subtype
12%
Cystic Fibrosis
12%
Sprague Dawley Rat
12%
Irritable Colon
12%
Prostaglandin E
12%
Butyrate
12%
Chronic Constipation
12%